Livongo announced a partnership with Glytec to offer eGlycemic Management System®, or eGMS®, to Livongo members. With this alliance, Livongo and Glytec will partner to deliver an expanded diabetes management solution that includes insulin titration, making managing diabetes easier for members and their providers.
Livongo Health, the diabetes management startup launched by former Allscripts CEO Glen Tullman, has landed a $52.5 million round of funding.
It could be a game-changer. The latest investment could not only help the company grow its diabetes coaching and management work, but also to take on the management of other chronic conditions.
>> Read full article
MobiHealthNews features Livongo’s $52.5M funding round
Technology-enabled diabetes management company Livongo Health has raised $52.5 million in new funding in a round co-led by General Catalyst, an existing investor, and international investment company Kinnevik. Other investors included Microsoft Ventures, American Investment Holdings, and EDBI, a Singapore-based fund whose portfolio includes WellTok, GoBalto, and Sotera Wireless. All previous investors also participated in the round.
Livongo has closed a new round of investment and will use funds to accelerate growth, add new chronic conditions, and speed international expansion.